Abraham M, Arroyo-Diaz N, Li Z, Zengel J, Sakamoto K, He B. Role of small hydrophobic protein of J paramyxovirus in virulence. J Virol. 2018;92(20):e00653–18.
Ayllon J, García-Sastre A, Martínez-Sobrido L. Rescue of recombinant Newcastle disease virus from cDNA. J Vis Exp. 2013;80:e50830.
Baron M, Barrett T. Rescue of rinderpest virus from cloned cDNA. J Virol. 1997;71(2):1265–71.
Beaty S, Park A, Won S, Hong P, Lyons M, Vigant F, Freiberg A, TenOever B, Duprex W, Lee B. Efficient and robust paramyxoviridae reverse genetics systems. mSphere. 2017;2(2):e00376.
Buchholz U, Finke S, Conzelmann K. Generation of Bovine Respiratory Syncytial Virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol. 1999;73(1):251–9.
Bukreyev A, Whitehead S, Bukreyeva N, Murphy B, Collins P. Interferon expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proc Natl Acad Sci. 1999;96(5):2367–72.
Bukreyev A, Belyakov I, Berzofsky J, Murphy B, Collins P. Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells. J Virol. 2001;75(24):12128–40.
Bukreyev A, Skiadopoulos M, McAuliffe J, Murphy B, Collins P, Schmidt A. More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved? Proc Natl Acad Sci. 2002;99(26):16987–91.
Bukreyev A, Huang Z, Yang L, Elankumaran S, St. Claire M, Murphy B, Samal S, Collins P. Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol. 2005;79(21):13275–84.
Bukreyev A, Skiadopoulos M, Murphy B, Collins P. Non segmented negative-strand viruses as vaccine vectors. J Virol. 2006;80(21):10293–306.
Calain P, Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol. 1993;67(8):4822–30.
Carnero E, Li W, Borderia A, Moltedo B, Moran T, Garcia-Sastre A. Optimization of human immunodeficiency virus Gag expression by Newcastle disease virus vectors for the induction of potent immune responses. J Virol. 2009;83(2):584–97.
Chanock R. Association of a new type of cytopathogenic myxovirus with infantile croup. J Exp Med. 1956;104(4):555–76.
Chanock R, Parrott R, Cook K, Andrews B, Bell J, Reichelderfer T, Kapikian A, Mastrota F, Huebner R. Newly recognized myxoviruses from children with respiratory disease. N Engl J Med. 1958;258(5):207–13.
Chellappa M, Dey S, Gaikwad S, Pathak D, Vakharia V. Rescue of a recombinant Newcastle disease virus strain R2B expressing green fluorescent protein. Virus Genes. 2017;53(3):410–7.
Chen Z, Xu P, Salyards G, Harvey S, Rada B, Fu Z, He B. Evaluating a parainfluenza virus 5-based vaccine in a host with pre-existing immunity against parainfluenza virus 5. PLoS One. 2012;7(11):e50144.
Chen Z, Zhou M, Gao X, Zhang G, Ren G, Gnanadurai C, Fu Z, He B. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein. J Virol. 2013;87(6):2986–93.
Chen Z, Gupta T, Xu P, Phan S, Pickar A, Yau W, Karls R, Quinn F, Sakamoto K, He B. Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice. Vaccine. 2015;33(51):7217–24.
Chen Z. Parainfluenza virus 5-vectored vaccines against human and animal infectious diseases. Rev Med Virol. 2017;28(2):e1965.
Clarke D, Sidhu M, Johnson J, Udem S. Rescue of mumps virus from cDNA. J Virol. 2000;74(10):4831–8.
Coelingh K, Winter C, Murphy B, Rice J, Kimball P, Olmsted R, Collins P. Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodies. J Virol. 1986;60(1):90–6.
Cornwell H, McCandlish I, Thompson H, Laird H, Wright N. Isolation of parainfluenza virus SV5 from dogs with respiratory disease. Vet Rec. 1976;98(15):301–2.
DiNapoli J, Kotelkin A, Yang L, Elankumaran S, Murphy B, Samal S, Collins P, Bukreyev A. Newcastle disease virus, a host range-restricted virus, as a vaccine for intranasal immunization against emerging pathogens. Proc Natl Acad Sci. USA 2007;104:9788–9793.
DiNapoli J, Yang L, Samal S, Murphy B, Collins P, Bukreyev A. Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine. 2010;29(1):17–25.
Doyle T. A hitherto unrecorded disease of fowls due to a filter-passing virus. J Comparative Pathol Therapeutic. 1927;40:144–69.
Elroy-Stein O, Moss B. Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proc Natl Acad Sci. 1990;87(17):6743–7.
Engeland C, Bossow S, Hudacek A, Hoyler B, Förster J, Veinalde R, Jäger D, Cattaneo R, Ungerechts G, Springfeld C. A Tupaia paramyxovirus vector system for targeting and transgene expression. J Gen Virol. 2017;98(9):2248–57.
Fang Y, Rowland R, Roof M, Lunney J, Christopher-Hennings J, Nelson E. A full-length cDNA infectious clone of north American type 1 porcine reproductive and respiratory syndrome virus: expression of green fluorescent protein in the Nsp2 region. J Virol. 2006;80(23):11447–55.
Fournier P, Schirrmacher V. Oncolytic Newcastle disease virus as cutting edge between tumor and host. Biology. 2013;2(3):936–75.
Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J. 1995;14(24):6087–94.
Gassen U, Collins F, Duprex W, Rima B. Establishment of a rescue system for canine distemper virus. J Virol. 2000;74(22):10737–44.
Ge J, Deng G, Wen Z, Tian G, Wang Y, Shi J, Wang X, Li Y, Hu S, Jiang Y, Yang C, Yu K, Bu Z, Chen H. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol. 2007;81(1):150–8.
Ge J, Wang X, Tao L, Wen Z, Feng N, Yang S, Xia X, Yang C, Chen H, Bu Z. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. J Virol. 2011;85(16):8241–52.
Ge J, Wang X, Tian M, Gao Y, Wen Z, Yu G, Zhou W, Zu S, Bu Z. Recombinant Newcastle disease viral vector expressing hemagglutinin or fusion of canine distemper virus is safe and immunogenic in minks. Vaccine. 2015;33(21):2457–62.
Grieves J, Yin Z, Garcia-Sastre A, Mena I, Peeples M, Risman H, Federman H, Sandoval M, Durbin R, Durbin J. A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats. Vaccine. 2018;36(26):3842–52.
Haller A, Miller T, Mitiku M, Coelingh K. Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. J Virol. 2000;74(24):11626–35.
He B, Paterson R, Ward C, Lamb R. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology. 1997;237(2):249–60.
Hoffman M, Banerjee A. An infectious clone of human parainfluenza virus type 3. J Virol. 1997;71(6):4272–7.
Honda K, Sakaguchi S, Nakajima C, Watanabe A, Yanai H, Matsumoto M, Ohteki T, Kaisho T, Takaoka A, Akira S, Seya T, Taniguchi T. Selective contribution of IFN- /signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci. 2003;100(19):10872–7.
Hu H, Roth J, Estevez C, Zsak L, Liu B, Yu Q. Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys. Vaccine. 2011;29(47):8624–33.
Hu H, Roth J, Yu Q. Generation of a recombinant Newcastle disease virus expressing two foreign genes for use as a multivalent vaccine and gene therapy vector. Vaccine. 2018;36(32):4846–50.
Hu Q, Chen W, Huang K, Baron M, Bu Z. Rescue of recombinant peste des petits ruminants virus: creation of a GFP-expressing virus and application in rapid virus neutralization test. Vet Res. 2012;43(1):48.
Huang Y, Chen Z, Huang J, Fu Z, He B. Parainfluenza virus 5 expressing the G protein of rabies virus protects mice after rabies virus infection. J Virol. 2015;89(6):3427–9.
Huang Z, Krishnamurthy S, Panda A, Samal S. Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist. J Virol. 2003;77(16):8676–85.
Huang Z, Elankumaran S, Yunus A, Samal S. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious Bursal disease virus (IBDV) protects against NDV and IBDV. J Virol. 2004;78(18):10054–63.
Hull R, Minner J, Smith J. New viral agents recovered from tissue cultures of monkey kidney cells. Am J Epidemiol. 1956;63(2):204–15.
International Committee on Taxonomy of Viruses (ICTV). 2019. International Committee on Taxonomy of Viruses (ICTV). [Online] Available at: https://talk.ictvonline.org/. Accessed 19 Jul 2019.
Kanabagatte Basavarajappa M, Kumar S, Khattar S, Gebreluul G, Paldurai A, Samal S. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens. Vaccine. 2014;32(28):3555–63.
Karron R, Makhene M, Gay K, Wilson M, Clements M, Murphy B. Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants. Pediatr Infect Dis J. 1996;15(8):650–4.
Kasel J, Frank A, Keitel W, Taber L, Glezen W. Acquisition of Serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children. J Virol. 1984;52(3):828–32.
Kast W. Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC- restricted and MHC-regulated; a model for MHC-disease associations. J Exp Med. 1986;164(3):723–38.
Kawano M, Kaito M, Kozuka Y, Komada H, Noda N, Nanba K, Tsurudome M, Ito M, Nishio M, Ito Y. Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain. Virology. 2001;284(1):99–112.
Khattar S, Collins P, Samal S. Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1. Vaccine. 2010;28(18):3159–70.
Khattar S, Manoharan V, Bhattarai B, LaBranche C, Montefiori D, Samal S. Mucosal immunization with Newcastle disease virus vector coexpressing HIV-1 Env and Gag proteins elicits potent serum, mucosal, and cellular immune responses that protect against Vaccinia virus Env and gag challenges. MBio. 2015;6(4):e01005.
Kim S, Samal S. Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing Green fluorescent protein. J Virol. 2010;84(5):2629–34.
Kim S, Xiao S, Shive H, Collins P, Samal S. Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 4 confer increased replication and syncytium formation in vitro but not increased replication and pathogenicity in chickens and ducks. PLoS One. 2013;8(1):e50598.
Kim S, Chen S, Jiang X, Green K, Samal S. Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice. J Virol. 2014;88(17):9718–27.
Kim S, Samal S. Newcastle disease virus as a vaccine vector for development of human and veterinary vaccines. Viruses. 2016;8(7):183.
Kim S, Paldurai A, Samal S. A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus. Virology. 2017;503:31–6.
Kim S, Samal S. Reverse genetics for Newcastle disease virus as a vaccine vector. Curr Protoc Microbiol. 2018;48:18.5.1–18.5.12.
Kim S, Samal S. Innovation in Newcastle disease virus vectored avian influenza vaccines. Viruses. 2019;11(3):300.
Kong D, Wen Z, Su H, Ge J, Chen W, Wang X, Wu C, Yang C, Chen H, Bu Z. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. Virology. 2012;432(2):327–35.
Kortekaas J, Dekker A, de Boer S, Weerdmeester K, Vloet R, Wit A, Peeters B, Moormann R. Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus. Vaccine. 2010a;28(11):2271–6.
Kortekaas J, de Boer S, Kant J, Vloet R, Antonis A, Moormann R. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine. 2010b;28(27):4394–401.
Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987;15(20):8125–48.
Kranveld F. A poultry disease in the Dutch East Indies. Ned Indisch Bl Diergeneeskd. 1926;38:448–50.
Krishnamurthy S, Huang Z, Samal S. Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology. 2000;278(1):168–82.
Kumar S, Nayak B, Collins P, Samal S. Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens. J Virol. 2011;85(13):6521–34.
Kuroya M, Ishida N, Shiratori T. Newborn virus pneumonia (type Sendai) II. Report: the isolation of a new virus possessing hemagglutinin activity. Yokohama Med Bull. 1953;4:217–33.
Laing E, Amaya M, Navaratnarajah C, Feng Y, Cattaneo R, Wang L, Broder C. Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species. Virol J. 2018;15(1):56.
Lamb RA, Parks GD. Paramyxoviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology: sixth edition, vol. 1. Philadelphia: Lippincott, Williams, and Wilkins; 2013. p. 957–95.
Le Mercier P, Jacob Y, Tanner K, Tordo N. A novel expression cassette of lyssavirus shows that the distantly related Mokola virus can rescue a defective rabies virus genome. J Virol. 2002;76(4):2024–7.
Le Nouen C, Brock L, Luongo C, McCarty T, Yang L, Mehedi M, Wimmer E, Mueller S, Collins P, Buchholz U, DiNapoli J. Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization. Proc Natl Acad Sci. 2014;111(36):13169–74.
Li B, Li X, Lan X, Yin X, Li Z, Yang B, Liu J. Rescue of Newcastle disease virus from cloned cDNA using an RNA polymerase II promoter. Arch Virol. 2011;156(6):979–86.
Li J, Hu H, Yu Q, Diel D, Li D, Miller P. Generation and characterization of a recombinant Newcastle disease virus expressing the red fluorescent protein for use in co-infection studies. Virol J. 2012;9(1):227.
Li Z, Gabbard J, Mooney A, Chen Z, Tompkins S, He B. Efficacy of parainfluenza virus 5 mutants expressing hemagglutinin from H5N1 influenza a virus in mice. J Virol. 2013;87(17):9604–9.
Liang B, Ngwuta J, Herbert R, Swerczek J, Dorward D, Amaro-Carambot E, Mackow N, Kabatova B, Lingemann M, Surman S, Yang L, Chen M, Moin S, Kumar A, McLellan J, Kwong P, Graham B, Schaap-Nutt A, Collins P, Munir S. Packaging and prefusion stabilization separately and additively increase the quantity and quality of respiratory syncytial virus (RSV)-neutralizing antibodies induced by an RSV fusion protein expressed by a parainfluenza virus vector. J Virol. 2016;90(21):10022–38.
Liang B, Kabatova B, Kabat J, Dorward D, Liu X, Surman S, Liu X, Moseman A, Buchholz U, Collins P, Munir S. Effects of alterations to the CX3C motif and secreted form of human Respiratory Syncytial Virus (RSV) G protein on immune responses to a parainfluenza virus vector expressing the RSV G protein. J Virol. 2019;93(7):e02043–18.
Liu J, Xue L, Hu S, Cheng H, Deng Y, Hu Z, Wang X, Liu X. Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity. Arch Virol. 2018;163(12):3365–71.
Marsh G, Virtue E, Smith I, Todd S, Arkinstall R, Frazer L, Monaghan P, Smith G, Broder C, Middleton D, Wang L. Recombinant Hendra viruses expressing a reporter gene retain pathogenicity in ferrets. Virol J. 2013;10(1):95.
Martinez-Sobrido L, Gitiban N, Fernandez-Sesma A, Cros J, Mertz S, Jewell N, Hammond S, Flano E, Durbin R, Garcia-Sastre A, Durbin J. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. J Virol. 2006;80(3):1130–9.
McCandlish I, Thompson H, Cornwell H, Wright N. A study of dogs with kennel cough. Vet Rec. 1978;102(14):293–301.
Merz DC, Scheild A, Choppin PW. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med. 1980;151(2):275–88.
Molouki A, Peeters B. Rescue of recombinant Newcastle disease virus: current cloning strategies and RNA polymerase provision systems. Arch Virol. 2016;162(1):1–12.
Mooney A, Li Z, Gabbard J, He B, Tompkins S. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice. J Virol. 2013;87(1):363–71.
Nagai Y, Klenk H, Rott R. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology. 1976;72(2):494–508.
Nakaya T, Cros J, Park M, Nakaya Y, Zheng H, Sagrera A, Villar E, Garcia-Sastre A, Palese P. Recombinant Newcastle disease virus as a vaccine vector. J Virol. 2001;75(23):11868–73.
Nayak B, Rout S, Kumar S, Khalil M, Fouda M, Ahmed L, Earhart K, Perez D, Collins P, Samal S. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One. 2009;4(8):e6509.
Nelson C, Pomeroy B, Schrall K, Park W, Lindeman R. An outbreak of conjunctivitis due to Newcastle Disease Virus (NDV) occurring in poultry workers. Am J Public Health Nations Health. 1952;42(6):672–8.
Newman J, Surman S, Riggs J, Hansen C, Collins P, Murphy B, Skiadopoulos M. Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse genetics. Virus Genes. 2002;24(1):77–92.
Panda A, Huang Z, Elankumaran S, Rockemann D, Samal S. Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb Pathog. 2004;36(1):1–10.
Park M, Shaw M, Munoz-Jordan J, Cros J, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, Basler C. Newcastle Disease Virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol. 2003;77(2):1501–11.
Park M, Steel J, Garcia-Sastre A, Swayne D, Palese P. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci. 2006;103(21):8203–8.
Peeters B, De Leeuw O, Koch G, Gielkens A. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol. 1999;73(6):5001–9.
Perrotta A, Been M. The self-cleaving domain from the genomic RNA of hepatitis delta virus: sequence requirements and the effects of denaturant. Nucleic Acids Res. 1990;18(23):6821–7.
Pham Q, Biacchesi S, Skiadopoulos M, Murphy B, Collins P, Buchholz U. Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo. J Virol. 2005;79(24):15114–22.
Phan S, Chen Z, Xu P, Li Z, Gao X, Foster S, Teng M, Tripp R, Sakamoto K, He B. A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5). Vaccine. 2014;32(25):3050–7.
Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, Dötsch C, Christiansen G, Billeter M. Rescue of measles viruses from cloned DNA. EMBO J. 1995;14(23):5773–84.
Rangaswamy U, Wang W, Cheng X, McTamney P, Carroll D, Jin H. Newcastle disease virus establishes persistent infection in tumor cells in vitro: contribution of the cleavage site of fusion protein and second sialic acid binding site of hemagglutinin-neuraminidase. J Virol. 2017;91(16):e00770–17.
Reisinger R, Heddleston K, Manthei C. A Myxovirus (SF-4) associated with shipping fever of cattle. J Am Med Assoc. 1959;135:147–52.
Romer-Oberdorfer A, Buchholz U, Mundt E, Mettenleiter T, Mebatsion T. Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol. 1999;80(11):2987–95.
Schmidt A, McAuliffe J, Huang A, Surman S, Bailly J, Elkins W, Collins P, Murphy B, Skiadopoulos M. Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates. J Virol. 2000;74(19):8922–9.
Schnell M, Mebatsion T, Conzelmann K. Infectious rabies viruses from cloned cDNA. EMBO J. 1994;13(18):4195–203.
Seligman S, Gould E. Live flavivirus vaccines: reasons for caution. Lancet. 2004;363(9426):2073–5.
Shirvani E, Paldurai A, Manoharan V, Varghese B, Samal S. A recombinant Newcastle disease virus (NDV) expressing S protein of infectious bronchitis virus (IBV) protects chickens against IBV and NDV. Sci Rep. 2018;8(1):11951.
Shirvani E, Varghese BP, Paldouri A, Samal S. A recombinant avian paramyxovirus type-3 (APMV-3) expressing HA protein of highly pathogenic avian influenza virus (HPAIV) protects chickens against HPAIV. Sci Rep. 2020;10:2221.
Skiadopoulos MH, Tao T, Surman S, Collins P, Murphy B. Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterparts. Vaccine. 1999;18(5–6):503–10.
Skiadopoulos M, Surman S, Durbin A, Collins P, Murphy B. Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes. Virology. 2000;272(1):225–34.
Skiadopoulos M, Surman S, Riggs J, Orvell C, Collins P, Murphy B. Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins. Virology. 2002;297(1):136–52.
Skiadopoulos M, Schmidt A, Riggs J, Surman S, Elkins W, St. Claire M, Collins P, Murphy B. Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic. J Virol. 2003;77(2):1141–8.
Skiadopoulos M, Biacchesi S, Buchholz U, Amaro-Carambot E, Surman S, Collins P, Murphy B. Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology. 2006;345(2):492–501.
Steglich C, Grund C, Ramp K, Breithaupt A, Höper D, Keil G, Veits J, Ziller M, Granzow H, Mettenleiter T, Römer-Oberdörfer A. Chimeric Newcastle disease virus protects chickens against avian influenza in the presence of maternally derived NDV immunity. PLoS One. 2013;8(9):e72530.
Subbiah M, Khattar S, Collins P, Samal S. Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickens. J Virol. 2011;85(11):5394–405.
Takeda M, Ohno S, Seki F, Nakatsu Y, Tahara M, Yanagi Y. Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol. 2005;79(22):14346–54.
Thibault P, Watkinson R, Moreira-Soto A, Drexler J, Lee B. Zoonotic potential of emerging paramyxoviruses: knowns and unknowns. Adv Virus Res. 2017;98:1–55.
Tompkins S, Lin Y, Leser G, Kramer K, Haas D, Howerth E, Xu J, Kennett M, Durbin R, Durbin J, Tripp R, Lamb R, He B. Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge. Virology. 2007;362(1):139–50.
Toro H, Zhao W, Breedlove C, Zhang Z, van Santen V, Yu Q. Infectious bronchitis virus S2 expressed from recombinant virus confers broad protection against challenge. Avian Dis. 2014;58(1):83–9.
Tsunekuni R, Hikono H, Tanikawa T, Kurata R, Nakaya T, Saito T. Recombinant avian paramyxovirus serotypes 2, 6, and 10 as vaccine vectors for highly pathogenic avian influenza in chickens with antibodies against Newcastle disease virus. Avian Dis. 2017;61(3):296–306.
Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, Starick E, Mundt E, Schirrmeier H, Mebatsion T, Mettenleiter T, Romer-Oberdorfer A. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci. 2006;103(21):8197–202.
Viktorova E, Khattar S, Kouiavskaia D, Laassri M, Zagorodnyaya T, Dragunsky E, Samal S, Chumakov K, Belov G. Newcastle disease virus-based vectored vaccine against poliomyelitis. J Virol. 2018;92(17):e00976–18.
Wang D, Phan S, DiStefano D, Citron M, Callahan C, Indrawati L, Dubey S, Heidecker G, Govindarajan D, Liang X, He B, Espeseth A. A single-dose recombinant parainfluenza virus 5-vectored vaccine expressing respiratory syncytial virus (RSV) F or G protein protected cotton rats and African green monkeys from RSV challenge. J Virol. 2017;91(11):e00066–17.
Wang J, Cong Y, Yin R, Feng N, Yang S, Xia X, Xiao Y, Wang W, Liu X, Hu S, Ding C, Yu S, Wang C, Ding Z. Generation and evaluation of a recombinant genotype VII Newcastle disease virus expressing VP3 protein of Goose parvovirus as a bivalent vaccine in goslings. Virus Res. 2015;203:77–83.
Wang J, Yang J, Ge J, Hua R, Liu R, Li X, Wang X, Shao Y, Sun E, Wu D, Qin C, Wen Z, Bu Z. Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry. Virol J. 2016;13(1):109.
Wang W, Cheng X, Buske P, Suzich J, Jin H. Attenuate Newcastle disease virus by codon modification of the glycoproteins and phosphoprotein genes. Virology. 2019;528:144–51.
Welch S, Chakrabarti A, Wiggleton Guerrero L, Jenks H, Lo M, Nichol S, Spiropoulou C, Albariño C. Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds. PLoS Negl Trop Dis. 2018;12(3):e0006326.
Wyatt L, Moss B, Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology. 1995;210(1):202–5.
Xiao S, Kumar M, Yang X, Akkoyunlu M, Collins P, Samal S, Pal U. A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen. Vaccine. 2011;29(32):5294–303.
Xiao S, Khattar S, Subbiah M, Collins P, Samal S. Mutation of the F-protein cleavage site of avian paramyxovirus type 7 results in furin cleavage, fusion promotion, and increased replication in vitro but not increased replication, tissue tropism, or virulence in chickens. J Virol. 2012;86(7):3828–38.
Yan Y, Samal S. Role of intergenic sequences in Newcastle disease virus RNA transcription and pathogenesis. J Virol. 2007;82(3):1323–31.
Yang L, Sanchez A, Ward J, Murphy B, Collins P, Bukreyev A. A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals. Virology. 2008;377(2):255–64.
Yoneda M, Guillaume V, Ikeda F, Sakuma Y, Sato H, Wild T, Kai C. Establishment of a Nipah virus rescue system. Proc Natl Acad Sci. 2006;103(44):16508–13.
Yoshida A, Samal S. Avian paramyxovirus type-3 as a vaccine vector: identification of a genome location for high level expression of a foreign gene. Front Microbiol. 2017;8:693.
Yoshida A, Kim S, Manoharan V, Varghese B, Paldurai A, Samal S. Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in Guinea pigs. Sci Rep. 2019;9(1):5520.
Yu G, Zu S, Zhou W, Wang X, Shuai L, Wang X, Ge J, Bu Z. Chimeric rabies glycoprotein with a transmembrane domain and cytoplasmic tail from Newcastle disease virus fusion protein incorporates into the Newcastle disease virion at reduced levels. J Vet Sci. 2017;18(1):351–9.
Zhang M, Ge J, Wen Z, Chen W, Wang X, Liu R, Bu Z. Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus. Arch Virol. 2016;162(2):359–67.
Zhang M, Ge J, Li X, Chen W, Wang X, Wen Z, Bu Z. Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice. Virol J. 2017;13(1):31.
Zhang X, Liu H, Liu P, Peeters B, Zhao C, Kong X. Recovery of avirulent, thermostable Newcastle disease virus strain NDV4-C from cloned cDNA and stable expression of an inserted foreign gene. Arch Virol. 2013;158(10):2115–20.
Zhao H, Peeters BP. Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication. J Gen Virol. 2003;84(4):781–8.
Zhao R, Sun J, Qi T, Zhao W, Han Z, Yang X, Liu S. Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge. Vaccine. 2017;35(18):2435–42.
Zhao W, Spatz S, Zhang Z, Wen G, Garcia M, Zsak L, Yu Q. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges. J Virol. 2014;88(15):8397–406.
Zhao W, Zhang Z, Zsak L, Yu Q. P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression. J Gen Virol. 2015;96(1):40–5.
Zhuo L, Mooney A, Gabbard J, Gao X, Xu P, Place R, Hogan R, Tompkins S, He B. Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge. J Virol. 2012;87(1):354–62.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4